(3-substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents

被引：99

作者：

Nomura, M ^{[1
]}

Kinoshita, S ^{[1
]}

Satoh, H ^{[1
]}

Maeda, T ^{[1
]}

Murakami, K ^{[1
]}

Tsunoda, M ^{[1
]}

Miyachi, H ^{[1
]}

Awano, K ^{[1
]}

机构：

[1] Kyorin Pharmaceut Co Ltd, Cent Res Labs, Nogi, Tochigi 3290114, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1999年 / 9卷 / 04期

关键词：

D O I：

10.1016/S0960-894X(99)00039-6

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of 3-[(2,4-dioxothiazolidin-5-yl)methyl]benzamide derivatives was prepared as part of a search for antidiabetic agents. A structure-activity relationship study of these compounds led to the identification of 5-[(2,4-dioxothiazolidin-5-yl)methyl] -2-methoxy-N-[[4-trifluoromethyl)phenyl]methyl]benzamide (KRP-297) as a candidate drug for the treatment of diabetes mellitus. (C) 1999 Elsevier Science Ltd. All rights reserved.

引用

页码：533 / 538

页数：6

共 15 条

[1] THE SYNTHESIS OF BRL-49653 - A NOVEL AND POTENT ANTIHYPERGLYCEMIC AGENT [J].

CANTELLO, BCC ;

CAWTHORNE, MA ;

HAIGH, D ;

HINDLEY, RM ;

SMITH, SA ;

THURLBY, PL .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (10) :1181-1184

[2] EFFECT OF NEAR NORMOGLYCEMIA FOR 2 YEARS ON PROGRESSION OF EARLY DIABETIC-RETINOPATHY, NEPHROPATHY, AND NEUROPATHY - THE OSLO STUDY [J].

DAHLJORGENSEN, K ;

BRINCHMANNHANSEN, O ;

HANSSEN, KF ;

GANES, T ;

KIERULF, P ;

SMELAND, E ;

SANDVIK, L ;

AAGENAES, O .

BRITISH MEDICAL JOURNAL, 1986, 293 (6556) :1195-1199

[3]

FELDTRASMUSSEN B, 1986, LANCET, V2, P1300

[4] MONITORING AND CONTROLLING THE PATIENT WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].

JASPAN, JB .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (02) :22-27

[5]

Johnson J.R., 1942, Organic Reactions, Org. React., V1, P210, DOI DOI 10.1002/0471264180.OR001.08

[6] AN ANTIDIABETIC THIAZOLIDINEDIONE IS A HIGH-AFFINITY LIGAND FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA(PPAR-GAMMA) [J].

LEHMANN, JM ;

MOORE, LB ;

SMITHOLIVER, TA ;

WILKISON, WO ;

WILLSON, TM ;

KLIEWER, SA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) :12953-12956

[7]

MOMOSE Y, 1991, Chemical and Pharmaceutical Bulletin (Tokyo), V39, P1440

[8] A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-α.: (PPAR-α) and PPAR-γ -: Effect of PPAR-α activation on abnormal lipid metabolism in liver of Zucker fatty rats [J].

Murakami, K ;

Tobe, K ;

Ide, T ;

Mochizuki, T ;

Ohashi, M ;

Akanuma, Y ;

Yazaki, Y ;

Kadowaki, T .

DIABETES, 1998, 47 (12) :1841-1847

[9] Diabetes complications: Why is glucose potentially toxic? [J].

Porte, D ;

Schwartz, MW .

SCIENCE, 1996, 272 (5262) :699-700

[10]

Rondestvedt C. S., 1976, ORG REACTIONS, V225, P259, DOI DOI 10.1002/0471264180.0R024.03

← 1 2 →